CPT2 and fetal growth restriction: When analyzing the pre-eclampsia subgroups separately (EOPE vs. LOPE, MPE vs. SPE, and IUGR vs. NIUGR), both globally and on each placental side, no significant differences in placental LCHAD, MCAD, CPT1A, and CPT2 mRNA expression were found (Supplementary Tables S2–S5).